Washington, June 24 -- Representative Emanuel Cleaver issued the following press release:
Today, U.S. Representative Emanuel Cleaver, II (D-MO) announced that he, along with Jeff Van Drew (R-NJ), has submitted an amendment to the National Defense Authorization Act for Fiscal Year 2027 (NDAA) to provide $5 million in federal funding for alpha-gal syndrome research. Alpha-gal syndrome is a life-threatening allergy triggered by tick bites that impacts approximately 500,000 Americans (https://pmc.ncbi.nlm.nih.gov/articles/PMC10390090/) across the United States, including tens of thousands of Missourians (https://www.kfvs12.com/2026/06/19/missouri-baker-makes-treats-people-suffering-tick-borne-allergy-bill-up-state-resources-sits-governors-desk...